{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:56:56Z","timestamp":1791280616805,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1002\/jps.23458","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T23:58:57Z","timestamp":1359503937000},"page":"1173-1181","source":"Crossref","is-referenced-by-count":101,"title":["Kinetic Analysis of the Toxicity of Pharmaceutical Excipients Cremophor EL and RH40 on Endothelial and Epithelial Cells"],"prefix":"10.1016","volume":"102","author":[{"given":"L\u00f3r\u00e1nd","family":"Kiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fruzsina R.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bocsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Veszelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"\u00d3zsv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3 G.","family":"Pusk\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piroska","family":"Szab\u00f3-R\u00e9v\u00e9sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria A.","family":"Deli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23458_bb0005","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","article-title":"Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery","volume":"1788","author":"Deli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.23458_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23458_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0300-483X(92)90162-8","article-title":"Evaluation of surfactant cytotoxicity potential by primary cultures of ocular tissues: I. Characterization of rabbit corneal epithelial cells and initial injury and delayed toxicity studies","volume":"76","author":"Grant","year":"1992","journal-title":"Toxicology"},{"key":"10.1002\/jps.23458_bb0020","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1002\/jps.23458_bb0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejps.2011.09.016","article-title":"Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20","volume":"45","author":"Weiszh\u00e1r","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23458_bb0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0022-3565(25)38962-7","article-title":"Potential neurotoxicity of the solvent vehicle for cyclosporine","volume":"268","author":"Windebank","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.23458_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000139354","article-title":"Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation","volume":"52","author":"Tatou","year":"1996","journal-title":"Pharmacology"},{"key":"10.1002\/jps.23458_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tox.2004.10.019","article-title":"Cremophor EL, a non-ionic surfactant, promotes Ca(2+)-dependent process of cell death in rat thymocytes","volume":"211","author":"Yamaguchi","year":"2005","journal-title":"Toxicology"},{"key":"10.1002\/jps.23458_bb0045","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1225::AID-CNCR23>3.0.CO;2-0","article-title":"Differential activity of Cremophor EL and paclitaxel in patients\u2019 tumor cells and human carcinoma cell lines in vitro","volume":"79","author":"Cs\u00f3ka","year":"1997","journal-title":"Cancer"},{"key":"10.1002\/jps.23458_bb0050","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/jps.21921","article-title":"Solubilizing efficiency and in vitro cytotoxicity of peptoad G","volume":"99","author":"Maroju","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23458_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/jmcc.1999.1078","article-title":"Immunosuppressive treatment affects cardiac and skeletal muscle mitochondria by the toxic effect of vehicle","volume":"32","author":"Sanchez","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1002\/jps.23458_bb0060","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jps.10176","article-title":"A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro","volume":"91","author":"Hugger","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23458_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tox.2006.02.002","article-title":"Oxidative stress induced by Cremophor EL is not accompanied by changes in NF-kappaB activation or iNOS expression","volume":"222","author":"Guti\u00e9rrez","year":"2006","journal-title":"Toxicology"},{"key":"10.1002\/jps.23458_bb0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12272-011-0405-8","article-title":"A combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine","volume":"34","author":"Cao","year":"2011","journal-title":"Arch Pharm Res"},{"key":"10.1002\/jps.23458_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","article-title":"Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs","volume":"58","author":"Gursoy","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1002\/jps.23458_bb0080","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s12272-010-1109-1","article-title":"Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation","volume":"33","author":"Sakeer","year":"2010","journal-title":"Arch Pharm Res"},{"key":"10.1002\/jps.23458_bb0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejpb.2008.10.009","article-title":"Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue","volume":"72","author":"Horv\u00e1t","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.23458_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jps.20431","article-title":"Effect of different surfactants in biorelevant medium on the secretion of a lipophilic compound in lipoproteins using Caco-2 cell culture","volume":"95","author":"Karpf","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23458_bb0095","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1211\/002235702225","article-title":"Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture","volume":"54","author":"Kristmundsd\u00f3ttir","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.23458_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-004-1377-8","article-title":"Permeability studies on in vitro blood-brain barrier models: Physiology, pathology, and pharmacology","volume":"25","author":"Deli","year":"2005","journal-title":"Cell Mol Neurobiol"},{"key":"10.1002\/jps.23458_bb0105","series-title":"Solubility, delivery, and ADME problems of drug and drug-candidates","first-page":"166","article-title":"Tools of modelling blood-brain barrier penetrability","author":"Veszelka","year":"2011"},{"key":"10.1002\/jps.23458_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23458_bb0115","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J"},{"key":"10.1002\/jps.23458_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuint.2006.08.006","article-title":"Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages","volume":"50","author":"Veszelka","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1002\/jps.23458_bb0125","first-page":"525","article-title":"A cell-microelectronic sensing technique for the screening of cytoprotective compounds","volume":"25","author":"\u00d3zsv\u00e1ri","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1002\/jps.23458_bb0130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/adt.2006.4.597","article-title":"Dynamic and label-free cell-based assays using the real-time cell electronic sensing system","volume":"4","author":"Atienza","year":"2006","journal-title":"Assay Drug Dev Technol"},{"key":"10.1002\/jps.23458_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tiv.2012.01.015","article-title":"The effect of sucrose esters on a culture model of the nasal barrier","volume":"26","author":"K\u00fcrti","year":"2012","journal-title":"Toxicol In Vitro"},{"key":"10.1002\/jps.23458_bb0140","unstructured":"Food and Drug Administration. Food and Drug Administration database for inactive ingredients in approved drug products. Accessed on 04 Dec 2012, at: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/."},{"key":"10.1002\/jps.23458_bb0145","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0006-3495(01)75737-2","article-title":"Mesoscopic simulation of cell membrane damage, morphology change and rupture by nonionic surfactants","volume":"81","author":"Groot","year":"2001","journal-title":"Biophys J"},{"key":"10.1002\/jps.23458_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1002\/jps.23458_bb0155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/gut.33.5.622","article-title":"Modulation of cellular phospholipid fatty acids and leukotriene B4 synthesis in the human intestinal cell (CaCo-2)","volume":"33","author":"Dias","year":"1992","journal-title":"Gut"},{"key":"10.1002\/jps.23458_bb0160","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbalip.2006.05.013","article-title":"Lipid metabolism in human endothelial cells","volume":"1761","author":"H\u00e9li\u00e8s-Toussaint","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.23458_bb0165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejps.2010.07.005","article-title":"Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes","volume":"41","author":"Christiansen","year":"2010","journal-title":"Eur J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915311412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915311412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:49:18Z","timestamp":1745952558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915311412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0022354915311412"],"URL":"https:\/\/doi.org\/10.1002\/jps.23458","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}